AOD-9604 vs Semaglutide: Which Weight Loss Peptide Is Right for You?
Verdict Summary
Semaglutide has vastly stronger clinical evidence for weight loss. AOD-9604 is a research compound with limited human data.
Medical Disclaimer: This comparison is for educational purposes only. Consult a healthcare provider before starting any peptide protocol. Full disclaimer →
At a Glance
| Dimension | AOD-9604 | Semaglutide |
|---|---|---|
| Mechanism | GH fragment — stimulates lipolysis | GLP-1 receptor agonist — appetite suppression |
| Evidence Level | Preclinical Only | Strong Human Clinical |
| Average Weight Loss | Limited human data | 10–15% body weight |
| Prescription Required | No (research compound) | Yes |
| Appetite Suppression | Minimal | Strong |
AOD-9604 Deep Dive
AOD-9604 is a modified fragment of human growth hormone (hGH) that stimulates lipolysis (fat breakdown) without the anabolic effects of full GH. Animal studies show fat reduction, but human clinical trials have not demonstrated significant weight loss. It failed to meet primary endpoints in Phase III trials for obesity.
How to Choose
Choose AOD-9604 if…
- •You are specifically researching GH fragment mechanisms
- •You want a non-prescription option (with the understanding that evidence is very limited)
Choose Semaglutide if…
- •Weight loss is your primary goal and you want proven results
- •You are willing to use a prescription medication
- •Clinical evidence is important to you
Consider Both If…
The evidence strongly favors Semaglutide for weight loss. AOD-9604 is not recommended as a primary weight loss intervention based on current evidence.
Frequently Asked Questions
More Comparisons
BPC-157 vs TB-500
BPC-157 excels at localized tendon, ligament, and gut healing. TB-500 is better for systemic muscle recovery and widespread inflammation.
Semaglutide vs Tirzepatide
Tirzepatide produces greater average weight loss in clinical trials. Semaglutide has a longer post-market safety record. Both are excellent options.
Ipamorelin vs CJC-1295
Ipamorelin and CJC-1295 work through complementary mechanisms and are almost always used together rather than as alternatives.
Ozempic vs Wegovy
Ozempic and Wegovy both contain Semaglutide. The difference is FDA indication and maximum dose — Wegovy is approved for weight management at higher doses.
Mounjaro vs Zepbound
Mounjaro and Zepbound both contain Tirzepatide. Mounjaro is approved for Type 2 diabetes; Zepbound for obesity. The active ingredient is identical.
Selank vs Semax
Selank is primarily anxiolytic — it reduces anxiety and improves mood. Semax is primarily a cognitive enhancer — it boosts focus, memory, and BDNF. They are frequently combined.